BIBLIOGRAFIA
[1] www.epicentro.iss.it/problemi/jacob/jacob.asp Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della salute (EpiCentro),
Istituto Superiore di Sanità.
[2] J. Collinge. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci (2001); 24: 519–50.
[3] I. Zerr, S. Poser. Clinical diagnosis and differential diagnosis of CJD and vCJD. With special emphasis on laboratory tests. APMIS (2002); 110: 88–
98.
[4] E. Kübler, B. Oesch, A. J. Raeber. Diagnosis of prion disease, British
Medical Bulletin (2003); 66:267-279.
[5] S.B. Prusiner, Molecular Biology of prion disease. Science 252 (1991);
1515 – 1522.
[6] S.B Prusiner, Prions, Proc. Natl. Acad. Sci. USA 95 (1998); 13363 –
13383.
[7] Soto C, Castilla J. The controversial protein-only hypothesis of prion propagation. Nat Med. 2004 Jul;10 Suppl:S63-7.
[8] Wadsworth JD, Joiner S, Hill AF, Campbell TA, Desbruslais M, Luthert PJ, Collinge J. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet. (2001); Jul 21;358(9277):171-80.
[9] Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) Opinion on The Safety of Human-derived Products with regard to Variant Creutzfeldt-Jakob Disease SCENIHR/003/05 Adopted
by the SCENIHR during the 7th plenary meeting of 28-29 September 2005.
[10] J Cuillé , PL Chelle, Experimental transmission of trembling to the goat,
CR Seances Acad. Sci. (1939); 208: 1058-1060.
[11] DC Gajdusek, CJ Gibbs, M. Alpers. Experimental transmission of a kuru-like syndrome to chimpanzees. Nature (1966); 209: 794-796.
[12] W.J. Hadlow. Scrapie and Kuru. Lancet (1959); 2: 289-290.
[13] W.J. Hadlow. Neuropathology and the scrapie- Kuru connections. Brain
[14] W.J. Hadlow. Reflections on the transmissible spongiform encephalopaties. Vet. Pathol. (1999); 36: 523-529.
[15] T. Alper, D.A. Haig, M.C. Clarke. The exceptionally small size of the scrapie agent, Biochem Biophys Res Commun. (1966); 22: 278-284. [16] I.H. Pattison, K.M. Jones. The possible nature of the transmissible
agent of scrapie, Vet. Rec. (1967); 80: 2-9.
[17] J.S. Griffith. Self-replication and scrapie. Nature (1967); 215:
1043-1044.
[18] S.B Prusiner. Novel proteinaceous infectious particles cause scrapie,
Science (1982); 136-144.
[19] S.B. Prusiner et al. Further purification and characterization of scrapie prion. Biochemistry (1982), 21:6942-6950.
[20] R.K. Meyer, M.P. McKinley, K.A. Bowman, M.B. Braunfeld, R.A. Barry, S.B. Prusiner, Separation and properties of cellular and scrapie prion proteins, Proc. Natl. Acad. Sci. USA 83 (1986); 2310 – 2314.
[21] SB Prusiner, DF Groth, DC Bolton, SB Kent, LE Hood. Purification and structural studies of a major scrapie prion protein. Cell (1984); 38:
127–34.
[22] B Oesch, D Westaway, M Walchli et al. A cellular gene encodes scrapie PrP27–30 protein. Cell (1985); 40: 735–46.
[23] M. Watarai, S. Kim, J. Erdenbaatar, S. Makino, M. Horiuchi, T. Shirahata, S. Sakaguchi, S. Katamine. Cellular prion protein promotes Brucella infection into macrophages. J. Exp. Med. 198 (2003); 5- 17. [24] D.C. Bolton, M.P. McKinley, S.B. Prusiner. Identification of a protein
that purifies with the scrapie prion. Science 218 (1982); 1309 – 1311. [25] J.M. Bockman, S.B. Prusiner, J. Tateishi, D.T. Kingsbury.
Immunoblotting of Creutzfeld-Jakob disease prion proteins: host species-specific epitopes. Ann. Neurol. 21 (1987); 589-595.
[26] Giulio Sideri Sonia Pasquinelli Le malattie prioniche. ARACNE Editrice
pag.11-12. I edizione Febbraio 2008.
[27] RG Will, M, Zeidler GE Stewart et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol (2000); 47: 575–82.
[28] MD Spencer, RS Knight, RG Will. First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features. BMJ (2002); 324: 1479–82.
[30] ME Bruce, A Boyle, S Cousens et al. Strain characterization of natural sheep scrapie and comparison with BSE. J Gen Virol (2002); 83: 695–
704.
[31] T Kitamoto, J Tateishi, T Tashima et al. Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies. Ann
Neurol (1986); 20: 204–8.
[32] CI Lasmezas, JP Deslys, R Demalmay et al. BSE transmission to macaques [letter]. Nature (1996); 381: 743–4.
[33] CJ Sigurdson, ES Williams, MW Miller, TR Spraker, KI O’Rouke, EA Hoover. Oral transmission and early lymphoid tropism of chronic wasting disease PrPres in mule deer fawns (Odocoileus hemionus). J
Gen Virol (1999); 80: 2757–64.
[34] AF Hill, M Zeidler, J Ironside, J Collinge. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet (1997); 349: 99–100. [35] Schreuder BE, Somerville RA. Bovine spongiform encephalopathy in
sheep? Rev Sci Tech. (2003); Apr;22(1):103-20. Review.
[36] van Keulen LJ, Schreuder BE, Vromans ME, Langeveld JP, Smits MA. Pathogenesis of natural scrapie in sheep. Arch Virol Suppl.
(2000);(16):57-71.
[37] Wadsworth JD, Joiner S, Hill AF, Campbell TA, Desbruslais M, Luthert PJ, Collinge J. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet. (2001); Jul 21;358(9277):171-80.
[38] Wild MA, Spraker TR, Sigurdson CJ, O'Rourke KI, Miller MW. Preclinical diagnosis of chronic wasting disease in captive mule deer (Odocoileus hemionus) and white-tailed deer (Odocoileus virginianus) using tonsillar biopsy. J Gen Virol. (2002); Oct 83(Pt 10):2629-34.
[39] Hilton DA, Ghani AC, Conyers L, Edwards P, McCardle L, Ritchie D, Penney M, Hegazy D, Ironside JW. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol. (2004); Jul
203(3):733-9.
[40] MP McKinley, RK Meyer, L Kenaga et al. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J Virol
(1991); 65: 1340–51.
[41] Schulz-Schaeffer WJ, Tschöke S, Kranefuss N, Dröse W, Hause-Reitner D, Giese A, Groschup MH, Kretzschmar HA. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol. (2000); Jan 156(1):51-6.
[42] Ritchie DL, Head MW, Ironside JW. Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting. Neuropathol Appl
Neurobiol. (2004); Aug 30(4):360-8.
[43] Hill AF, Collinge J. Prion strains and species barriers. Contrib Microbiol.
2004;11:33-49
[44] J Cuille, PL Chelle. La tremblante du mouton est bien inoculable. CR
Seances Acad Sci (1938); 206: 78–9.
[45] RL Chandler. Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet (1961); 1: 1378–9.
[46] RF Marsh, RH Kimberlin. Comparison of scrapie and transmissible mink encephalopathy in hamsters. II. Clinical signs, pathology, and pathogenesis. J Infect Dis (1975); 131: 104–10.
[47] AJ Raeber, S Brandner, MA Klein et al. Transgenic and knockout mice in research on prion diseases. Brain Pathol (1998); 8: 715–33.
[48] H Bueler, A Raeber, A Sailer, M Fischer, A Aguzzi, C Weissmann. High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol Med
(1994); 1: 19–30.
[49] A Thomzig, C Kratzel, G Lenz, D Kruger, M Beekes. Widespread PrP(Sc) accumulation in muscles of hamsters orally infected with scrapie. EMBO Rep (2003); 4: 1–4.
[50] PJ Bosque, C Ryou, G Telling et al. Prions in skeletal muscle. Proc
Natl Acad Sci USA (2002); 99: 3812–7.
[51] Kuczius T, Groschup MH. Differences in proteinase K resistance and neuronal deposition of abnormal prion proteins characterize bovine spongiform encephalopathy (BSE) and scrapie strains. Mol Med. (1999);
Jun;5(6):406-18.
[52] Pan T, Colucci M, Wong BS, Li R, Liu T, Petersen RB, Chen S, Gambetti P, Sy MS. Novel differences between two human prion strains revealed by two-dimensional gel electrophoresis. J Biol Chem. (2001);
Oct 5;276(40):37284-8. Epub 2001 Aug 6.
[53] Thuring CM, Erkens JH, Jacobs JG, Bossers A, Van Keulen LJ, Garssen GJ, Van Zijderveld FG, Ryder SJ, Groschup MH, Sweeney T, Langeveld JP. Discrimination between scrapie and bovine spongiform encephalopathy in sheep by molecular size, immunoreactivity, and glycoprofile of prion protein. J Clin Microbiol.
[54] Head MW, Bunn TJ, Bishop MT, McLoughlin V, Lowrie S, McKimmie CS, Williams MC, McCardle L, MacKenzie J, Knight R, Will RG, Ironside JW. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Ann Neurol. (2004)
Jun;55(6):851-9.
[55] Notari S, Capellari S, Giese A, Westner I, Baruzzi A, Ghetti B, Gambetti P, Kretzschmar HA, Parchi P. Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J Biol Chem. (2004) Apr 16;279(16):16797-804. Epub 2004 Jan
29.
[56] Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann
Neurol. (1999) Aug;46(2):224-33.
[57] Schoch G, Seeger H, Bogousslavsky J, Tolnay M, Janzer RC, Aguzzi A, Glatzel M. Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease. PLoS Med. 2006 Feb;3(2):e14. Epub 2005
Dec 20.
[58] Wadsworth JD, Hill AF, Beck JA, Collinge J. Molecular and clinical classification of human prion disease. Br Med Bull. (2003);66:241-54.
Review.
[59] Korth C, Stierli B, Streit P, Moser M, Schaller O, Fischer R, Schulz-Schaeffer W, Kretzschmar H, Raeber A, Braun U, Ehrensperger F, Hornemann S, Glockshuber R, Riek R, Billeter M, Wüthrich K, Oesch B. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature. (1997); Nov 6;390(6655):74-7.
[60] Korth C, Streit P, Oesch B. Monoclonal antibodies specific for the native, disease-associated isoform of the prion protein. Methods
Enzymol. (1999);309:106-22.
[61] Paramithiotis E, Pinard M, Lawton T, LaBoissiere S, Leathers VL, Zou WQ, Estey LA, Lamontagne J, Lehto MT, Kondejewski LH, Francoeur GP, Papadopoulos M, Haghighat A, Spatz SJ, Head M, Will R, Ironside J, O'Rourke K, Tonelli Q, Ledebur HC, Chakrabartty A, Cashman NR. A prion protein epitope selective for the pathologically misfolded conformation. Nat Med. (2003); Jul;9(7):893-9.
[62] Zwald et al. A novel blood based TSE diagnostic test, oral presentation
First International Conference of the European Network of Excellence, Paris, May 2004.
[63] Safar JG, Scott M, Monaghan J, Deering C, Didorenko S, Vergara J, Ball H, Legname G, Leclerc E, Solforosi L, Serban H, Groth D, Burton DR, Prusiner SB, Williamson RA. Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol. (2002);
Nov;20(11):1147-50. Epub 2002; Oct 21.
[64] Bellon A, Seyfert-Brandt W, Lang W, Baron H, Gröner A, Vey M. Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity. J Gen Virol. (2003); Jul;84(Pt
7):1921-5.
[65] MJ Schmerr, A Jenny, RC Cutlip. Use of capillary sodium dodecyl sulfate gel electrophoresis to detect the prion protein extracted from scrapie-infected sheep. J Chromatogr (1997); 697: 223–9.
[66] MJ Schmerr, AL Jenny, MS Bulgin et al. Use of capillary electrophoresis and fluorescent labeled peptides to detect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy. J Chromatogr (1999); 853:
207–14.
[67] Bosque PJ, Prusiner SB. Cultured cell sublines highly susceptible to prion infection. J Virol. (2000); May 74(9):4377-86.
[68] Enari M, Flechsig E, Weissmann C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc Natl Acad Sci U S A. (2000) Jul
31;98(16):9295-9. Epub 2001 Jul 24.
[69] Winklhofer KF, Hartl FU, Tatzelt J. A sensitive filter retention assay for the detection of PrP(Sc) and the screening of anti-prion compounds.
FEBS Lett. (2001) Aug 10;503(1):41-5.
[70] Sakudo A, Nakamura I, Ikuta K, Onodera T. Recent developments in prion disease research: diagnostic tools and in vitro cell culture models.
J Vet Med Sci. (2007) Apr;69(4):329-37. Review.
[71] Barnard G, Helmick B, Madden S, Gilbourne C, Patel R. The measurement of prion protein in bovine brain tissue using differential extraction and DELFIA as a diagnostic test for BSE. Luminescence.
2000 Nov-Dec;15(6):357-62. Erratum in: Luminescence (2001) Mar-Apr;16(2):211.
[72] GP Saborio, B Permanne, C Soto. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature (2001);
411: 810–3.
[73] C Soto, GP Saborio, L Anderes. Cyclic amplification of protein misfolding: application to prion-related disorders and beyond. Trends
[74] Castilla J, Saá P, Hetz C, Soto C. In vitro generation of infectious scrapie prions. Cell. (2005) Apr 22;121(2):195-206.
[75] Saá P, Castilla J, Soto C. Presymptomatic detection of prions in blood.
Science. (2006) Jul 7;313(5783):92-4.
[76] Kübler E, Oesch B, Raeber AJ. Diagnosis of prion diseases. Source Prionics AG, Schlieren, Switzerland. Br Med Bull. (2003);66:267-79. [77] Murayama Y, Yoshioka M, Horii H, Takata M, Miura K, Shinagawa M.
Specific detection of prion antigenic determinants retained in bovine meat and bone meal by flow microbead immunoassay. J Appl Microbiol.
(2006) Aug;101(2):369-76.
[78] J Bieschke, A Giese, W Schulz-Schaeffer et al. Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc Natl Acad Sci USA
(2000); 97: 5468–73.
[79] J Schmitt, M Beekes, A Brauer, T Udelhoven, P Lasch, D Naumann. Identification of scrapie infection from blood serum by Fourier transform infrared spectroscopy. Anal Chem (2002); 74: 3865–8.
[80] Giese A, Bieschke J, Eigen M, Kretzschmar HA. Putting prions into focus: application of single molecule detection to the diagnosis of prion diseases. Arch Virol Suppl. (2000);(16):161-71.
[81] Schmitt J, Beekes M, Brauer A, Udelhoven T, Lasch P, Naumann D. Identification of scrapie infection from blood serum by Fourier transform infrared spectroscopy. Anal Chem. (2002) Aug 1;74(15):3865-8.
[82] Bieschke J, Giese A, Schulz-Schaeffer W, Zerr I, Poser S, Eigen M, Kretzschmar H. Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc
Natl Acad Sci U S A (2000); 97, 5468-5473.
[83] Rhie A, Kirby L, Sayer N, Wellesley R, Disterer P, Sylvester I, Gill A, Hope J, James W, Tahiri-Alaoui A. Characterization of 2'-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion. J Biol Chem. (2003); Oct
10;278(41):39697-705. Epub 2003 Aug 5.
[84] Sayer NM, Cubin M, Rhie A, Bullock M, Tahiri-Alaoui A, James W. Structural determinants of conformationally selective, prion-binding aptamers. J Biol Chem. (2004); Mar 26;279(13):13102-9. Epub 2004
Jan 7.
[85] Weiss S, Proske D, Neumann M, Groschup MH, Kretzschmar HA, Famulok M, Winnacker EL. RNA aptamers specifically interact with the prion protein PrP. J Virol. (1997); Nov,71(11):8790-7.
[86] GM Shaked, Y Shaken, Z Kariv-Inbal, M Halimi, I Avraham, R Gabizon. A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases. J Biol Chem (2001);
276: 31479–82.
[87] Furukawa H, Doh-ura K, Okuwaki R, Shirabe S, Yamamoto K, Udono H, Ito T, Katamine S, Niwa M. A pitfall in diagnosis of human prion diseases using detection of protease-resistant prion protein in urine. Contamination with bacterial outer membrane proteins. J Biol Chem.
(2004); May 28;279(22):23661-7. Epub 2004 Mar 18.
[88] Head MW, Kouverianou E, Taylor L, Green A, Knight R. Evaluation of urinary PrPSc as a diagnostic test for sporadic, variant, and familial CJD. Neurology. (2005); May 24;64(10):1794-6.
[89] Baxter HC, Fraser JR, Liu WG, Forster JL, Clokie S, Steinacker P, Otto M, Bahn E, Wiltfang J, Aitken A. Specific 14-3-3 isoform detection and immunolocalization in prion diseases. Biochem Soc Trans.
(2002); Aug;30(4):387-91. Review.
[90] Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med. (1996); Sep 26;335(13):924-30.
[91] Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease.
Ann Neurol. (1998); Jan;43(1):32-40.
[92] Otto M, Wiltfang J, Tumani H, Zerr I, Lantsch M, Kornhuber J, Weber T, Kretzschmar HA, Poser S. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci
Lett. (1997); Apr 11;225(3):210-2.
[93] Green AJ, Thompson EJ, Stewart GE, Zeidler M, McKenzie JM, MacLeod MA, Ironside JW, Will RG, Knight RS. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. (2001);
Jun;70(6):744-8.
[94] G Miele, J Manson, M Clinton. A novel erythroid-specific marker of transmissible spongiform encephalopathies. Nat Med (2001); 7: 361–4. [95] B Brenig, E Schutz, H Urnovitz. [Cellular nucleic acids in serum and
plasma as new diagnostic tools]. Berl Munch Tierarztl Wochenschr
(2002); 115: 122–4.
[96] Schmerr MJ, Jenny AL, Bulgin MS, Miller JM, Hamir AN, Cutlip RC, Goodwin KR. Use of capillary electrophoresis and fluorescent labeled
are infected with a transmissible spongiform encephalopathy. J
Chromatogr A. (1999); 853, 207-214.
[97] Cervenakova L, Brown P, Soukharev S, Yakovleva O, Diringer H, Saenko EL, Drohan WN. (2003b): Failure of immunocompetitive capillary electrophoresis assay to detect disease-specific prion protein in buffy coat from humans and chimpanzees with Creutzfeldt-Jakob disease. Electrophoresis (2003); 24, 853-859.
[98] Soto C, Anderes L, Suardi S, Cardone F, Castilla J, Frossard MJ, Peano S, Saa P, Limido L, Carbonatto M, Ironside J, Torres JM, Pocchiari M, Tagliavini F. Presymptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett. (2005); 579, 638-642. [99] Grosset A., Moskowitz K., Nelsen C., Pan T., Davidson E., Orser CS.
Rapid presymptomatic detection of PrPSc via conformationally responsive palindromic PrP peptides. Peptides (2005); Nov;26(11):2193-200. Epub 2005 Apr 14.
[100] Lane A., Stanley CJ, Dealer S, Wison SM. Polymeric ligands with specificity for aggregated prion protein. Clin. Chem. (2003), 49,
1774-1775.
[101] World Health Organization. WHO Guidelines on Transmissible Spongiform Encephalopathies in relation to Biological and Pharmaceutical Products. (2003).
[102] HPA Press Statement. 4th case of variant CJD infection associated with blood transfusion. (2007); Jan.
[103] Guideline for Industry: Validation of analytical procedures: Text and Methodology ICH Q2(R1). Current Step 4 version Parent Guideline dated 27 October 1994 (Complementary Guideline on Methodology dated 6 November 1996 incorporated in November 2005). [104] Committee for Medicinal Products for Human Use (CHMP). Position
statement on Creutzfeldt-Jacobs disease and plasma -derived and urine-derived medicinal products >, EMEA/CPMP/BWP/2879/02 Rev.01,
published in June 2004.
[105] Committee for Proprietary Products for Human Use (CPMP). Note for Guidance plasma derived medicinal products>, EMEA/CPMP/BWP/269/95 Rev.03, published in January 2001.
[106] Committee for Proprietary Products for Human Use (CPMP). Guideline on the investigation of Manufacturing processes for plasma derived medicinal products with regard to vCJD risk>, EMEA/CPMP/BWP/5136/03, October 2004.
[107] ME Bruce, RG Will, JW Ironside et al. Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature (1997); 389:
